| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959454 | Journal of the American College of Cardiology | 2005 | 7 Pages |
Abstract
A subcutaneous-only, short-term protocol of GM-CSF is effective in promoting coronary collateral artery growth among patients with CAD. However, the drug's safety regarding the occurrence of acute coronary syndrome is questionable.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephan MD, Rainer MD, Pascal MD, Stephan MD, Christian (FACC, FESC),